Skip to main content
Max Sung, MD, Oncology, New York, NY

MaxWSungMD

Oncology New York, NY

Associate Professor, Medicine, Icahn School of Medicine

Overview of Dr. Sung

Dr. Max Sung is an oncologist in New York, NY and is affiliated with multiple hospitals in the area, including The Mount Sinai Hospital, Mount Sinai West, Mount Sinai Morningside, and Mount Sinai Beth Israel. He received his medical degree from Albert Einstein College of Medicine of Yeshiva University and has been in practice 37 years. Dr. Sung accepts several types of health insurance, listed below. He is one of 188 doctors at The Mount Sinai Hospital and one of 122 doctors at Mount Sinai Beth Israel who specialize in Oncology. He has more than 70 publications and over 500 citings.

  • Office

    Mount Sinai Hospital-Ruttenberg Treatment Center
    1470 Madison Avenue Hess Center
    New York, NY 10029

Education & Training

  • Montefiore Medical Center/Albert Einstein College of Medicine (Moses and Weiler Campuses)
    Montefiore Medical Center/Albert Einstein College of Medicine (Moses and Weiler Campuses)Residency, Internal Medicine, 1980 - 1983
  • Albert Einstein College of Medicine
    Albert Einstein College of MedicineClass of 1980

Certifications & Licensure

  • NY State Medical License
    NY State Medical License 1983 - 2025
  • American Board of Internal Medicine Internal Medicine
  • American Board of Internal Medicine Medical Oncology

Clinical Trials

Publications & Presentations

PubMed

Journal Articles

  • Classification for Long-Term Survival in Oligometastatic Patients Treated with Ablative Radiotherapy: A Multi-Institutional Pooled Analysis  
    Julian C Hong, A William Blackstock, Joseph K Salama, Paul Okunieff, Michael T Milano, James J Urbanic, Ralph R Weichselbaum, Johnny Kao, Max W Sung, Steven J Chmura, PLoS One

Grant Support

  • Clinical Trial: Adenoviral Vector Delivery Of The Human Interleukin-12 CDNA In MNational Center For Research Resources2008–2009
  • Trial Of Human Interleukin-12 CDNA In Metastatic Colorectal Cancer To The LiverNational Center For Research Resources2007
  • Phase I Trial Of Adenoviral Vector Delivery Of The Human Interleukin-12 CDNANational Center For Research Resources2006
  • Phase I Trial Of Adenoviral Vector Delivery Of The Human Inteleukin-12 CDNA BNational Center For Research Resources2005
  • Clinical Trial Of Adenoviral Vector Delivery Of The Herpes Thymidine Kinase (National Center For Research Resources2005
  • Phase I Trial Of Adenoviral Vector Delivery Of The Human Inteleukin-12 CDNA B...National Center For Research Resources2004
  • Clinical Trial Of Adenoviral Vector Delivery Of The Herpes Thymidine Kinase (...National Center For Research Resources2004
  • Combination Gene Therapy In Colorectal CancerNational Cancer Institute2000–2003
  • Phase I Trial Of Adenoviral Vector Delivery Of The Herpes Simplex ThymidineNational Center For Research Resources1998–2002

Insurance Accepted

  • Aetna Choice POS II
    Aetna HMO
    BCBS Blue Card PPO
    CIGNA HMO
    CIGNA Open Access
    CIGNA PPO
    Empire BCBS HMO
    Empire BCBS PPO
    First Health PPO
    GHI PPO
    Great West PPO
    HIP of New York - Select PPO
    Horizon BCBS PPO
    Humana ChoiceCare Network PPO
    Multiplan PHCS PPO
    Multiplan PPO
    MVP Healthcare PPO
    Oxford Health Freedom
    Oxford Health Liberty
    United Healthcare - Direct Choice Plus POS
    United Healthcare - Direct Options PPO
  • Please verify your coverage with the provider's office directly when scheduling an appointment